Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

David Douglass to Humans

This is a "connection" page, showing publications David Douglass has written about Humans.

 
Connection Strength
  
 
 
0.163
  
  1. Douglass DP, Coffin CM, Randall RL, Yang Y, Barkauskas DA, Million L, McCarville MB, Pappo AS, Weiss AR, Spunt SL. Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332. Pediatr Blood Cancer. 2024 Aug; 71(8):e31062.
    View in: PubMed
    Score: 0.037
  2. Douglass DP, Navid F, Weiss AR. The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors. Paediatr Drugs. 2022 Sep; 24(5):433-445.
    View in: PubMed
    Score: 0.033
  3. Douglass DP, Stine KC, Farrar JE. A Novel Germline TP53 Mutation in a Patient With Li-Fraumeni Syndrome: Resolving a Variant of Uncertain Significance. J Pediatr Hematol Oncol. 2021 Nov 01; 43(8):e1220-e1222.
    View in: PubMed
    Score: 0.031
  4. Murphy LD, Orman GM, Bridge JA, Bajaj G, Gardner JM, Douglass DP. Primary superficial Ewing sarcoma: A unique entity? A case report including novel findings of ELF3 and TNFRSF14 copy number loss. J Cutan Pathol. 2020 Oct; 47(10):970-975.
    View in: PubMed
    Score: 0.028
  5. Crane JN, Douglass DP, Oberoi S, Collins NB, Gupta A, Metts JL, Avutu V, Dela Cruz FS, Davis JL, Federman NC, Hiniker SM, Laetsch TW, Linardic CM, Navid F, Saab R, Shulman DS, Shern JF, Soragni A, Stewart EA, Terezakis S, Weigel BJ, Weiss AR. Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group. Eur J Cancer. 2025 Aug 26; 226:115600.
    View in: PubMed
    Score: 0.010
  6. Gupta M, Kannappan S, Jain M, Douglass D, Shah R, Bose P, Narendran A. Development and validation of a 21-gene prognostic signature in neuroblastoma. Sci Rep. 2023 08 02; 13(1):12526.
    View in: PubMed
    Score: 0.009
  7. Blackburn PR, Douglass DP, Ramakrishnaiah RH, Montgomery CO, Shi Z, Wheeler DA, Koo SC. Neonatal osteoblastic tumor with a novel PTBP1::FOSB fusion. Genes Chromosomes Cancer. 2023 10; 62(10):611-616.
    View in: PubMed
    Score: 0.009
  8. Lievens C, Berdy G, Douglass D, Montaquila S, Lin H, Simmons P, Carlisle-Wilcox C, Vehige J, Haque S. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study. Cont Lens Anterior Eye. 2019 08; 42(4):443-449.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.